Carisma Therapeutics, Inc. - Current Ratio

The Current Ratio as of July 2026 (TTM) for Carisma Therapeutics, Inc. (CARM) is 0.86

According to Carisma Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.86. This represents a change of -17.17% compared to the average of 1.04 of the last 4 quarters.

Carisma Therapeutics, Inc. (CARM) Historical Current Ratio (quarterly & annually)

How has CARM Current Ratio performed in the past?

The mean historical Current Ratio of Carisma Therapeutics, Inc. over the last ten years is 5.99. The current 0.86 Current Ratio has changed 1.34% with respect to the historical average. Over the past ten years (40 quarters), CARM's Current Ratio was at its highest in in the March 2022 quarter at 21.32. The Current Ratio was at its lowest in in the June 2025 quarter at 0.48.

Carisma Therapeutics, Inc. (CARM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Carisma Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carisma Therapeutics, Inc. (CARM) Average Current Ratio

How has CARM Current Ratio performed in the past?

The current Current Ratio of Carisma Therapeutics, Inc. (CARM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carisma Therapeutics, Inc. (CARM) Current Ratio vs. Peers

How is CARM’s Current Ratio compared to its peers?

Carisma Therapeutics, Inc.’s Current Ratio is less than Jasper Therapeutics, Inc. (2.26), less than Onconetix, Inc. (1.41), less than Enveric Biosciences, Inc. (11.67), less than SciSparc Ltd. (2.41), less than Silexion Therapeutics Ltd. (1.00), less than Salarius Pharmaceuticals, Inc. (1.84), less than Revelation Biosciences, Inc. (10.02), less than CDT Equity Inc. (2.09), less than Indaptus Therapeutics, Inc. (2.34), less than Aspire Biopharma Holdings, Inc. (2.26),

Build a custom stock screener for Carisma Therapeutics, Inc. (CARM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carisma Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carisma Therapeutics, Inc. (CARM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carisma Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.